Comparative pharmacoeconomic evaluation of the use of specific drug treatment for endometriosis

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Dienogest in long-term treatment of endometriosis via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
• Differences in characteristics among 1,000 women with endometriosis based on extent of disease via openalex
• Endometriosis via openalex
• Endometriosis-associated infertility via openalex
• Endometriosis: cost estimates and methodological perspective via openalex
• Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases via openalex
• <i>Endometriosis and Infertility</i> via openalex
• Progestagens and anti-progestagens for pain associated with endometriosis via openalex
• W2093629698 via openalex
• W2021687464 via openalex
• W2101417341 via openalex

Cited by (1)

• Correction of immune disorders and changes in the protein/lipid spectrum of circulating erythrocyte membranes in adenomiosis 2018

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00